ArticleOncotarget2015
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Yoko Hari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleOncotarget2015
Yoko Hari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.